Latest portfolio news

Yonalink Partners with AI4LUNGS

BC Platforms and NTT Group announce exclusive collaboration

Genialis uses machine learning to personalize cancer treatment outcomes

New Genialis RNA biomarker accurately predicts KRAS outcomes in lung cancer patients

Nucleai and GoPath Diagnostics announce strategic collaboration

Merck’s M Ventures supports Nucleai’s spatial AI biomarker technology for clinical trial enrolment

Nucleai and Altis Labs are transforming clinical trials through AI innovation

Carevive partners with Canopy Cancer Collective

Mika selected for White House initiative